An Open-Label Safety Trial of Enfuvirtide (T-20/RO 29-9800, HIV-1 Fusion Inhibitor) in Combination With Free Choice Antiviral Regimen in Thai Patients With Advanced HIV Infection
Phase of Trial: Phase IV
Latest Information Update: 14 Jul 2016
At a glance
- Drugs Enfuvirtide (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Roche
- 14 Jul 2016 Last checked against ClinicalTrials.gov record.
- 20 Jan 2010 Status changed from active, no longer recruiting to completed as reported by Roche record.
- 20 Jan 2010 Planned number of patients changed from 20 to 30 as reported by Roche record.